BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 18983534)

  • 21. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Segmental Vitiligo.
    van Geel N; Speeckaert R
    Dermatol Clin; 2017 Apr; 35(2):145-150. PubMed ID: 28317524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Segmental and generalized vitiligo: both forms demonstrate inflammatory histopathological features and clinical mosaicism.
    Attili VR; Attili SK
    Indian J Dermatol; 2013 Nov; 58(6):433-8. PubMed ID: 24249893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes.
    Ezzedine K; Le Thuaut A; Jouary T; Ballanger F; Taieb A; Bastuji-Garin S
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):134-9. PubMed ID: 24127636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vitiligo--loss of cutaneous pigmentation].
    Sitek JC
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2370-2. PubMed ID: 16998548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional profiling of melanocytes from patients with vitiligo vulgaris.
    Strömberg S; Björklund MG; Asplund A; Rimini R; Lundeberg J; Nilsson P; Pontén F; Olsson MJ
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):162-71. PubMed ID: 18426409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes?
    Davids LM; du Toit E; Kidson SH; Todd G
    Clin Exp Dermatol; 2009 Mar; 34(2):246-8. PubMed ID: 18828846
    [No Abstract]   [Full Text] [Related]  

  • 28. Segmental forms of autosomal dominant skin disorders: the puzzle of mosaicism.
    Itin PH; Buechner SA
    Am J Med Genet; 1999 Aug; 85(4):351-4. PubMed ID: 10398258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
    Vanscheidt W; Hunziker T
    Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo.
    Kingo K; Aunin E; Karelson M; Rätsep R; Silm H; Vasar E; Kõks S
    J Dermatol Sci; 2008 Oct; 52(1):39-46. PubMed ID: 18514490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo.
    Dwivedi M; Gupta K; Gulla KC; Laddha NC; Hajela K; Begum R
    Br J Dermatol; 2009 Jul; 161(1):63-9. PubMed ID: 19416237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Familial occurrence of a type 2 segmental manifestation of cutaneous leiomyomatosis].
    Renner R; Sticherling M
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):695-9. PubMed ID: 16173977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of T cells in early evolving segmental vitiligo.
    Shin J; Kang HY; Kim KH; Park CJ; Oh SH; Lee SC; Lee S; Choi GS; Hann SK
    Clin Exp Dermatol; 2016 Aug; 41(6):671-4. PubMed ID: 27334675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitiligo therapy: where are we now?
    Arroyo MP; Tift L
    J Drugs Dermatol; 2003 Aug; 2(4):404-8. PubMed ID: 12884463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population.
    Laberge GS; Birlea SA; Fain PR; Spritz RA
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):206-8. PubMed ID: 18426414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetics of vitiligo].
    Lacour JP; Ortonne JP
    Ann Dermatol Venereol; 1995; 122(4):167-71. PubMed ID: 8526411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo.
    Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI
    G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression analysis of miRNA in peripheral blood mononuclear cells of patients with non-segmental vitiligo.
    Wang Y; Wang K; Liang J; Yang H; Dang N; Yang X; Kong Y
    J Dermatol; 2015 Feb; 42(2):193-7. PubMed ID: 25495156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients.
    Ezzedine K; Gauthier Y; Léauté-Labrèze C; Marquez S; Bouchtnei S; Jouary T; Taieb A
    J Am Acad Dermatol; 2011 Nov; 65(5):965-71. PubMed ID: 21616559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.